Division of Translational Cancer Research
551 – 560 of 692
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours
- Contribution to journal › Article
-
Mark
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
- Contribution to journal › Article
-
Mark
Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications.
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
- Contribution to journal › Article
- 2015
-
Mark
Differential regulation of HIF-1α and HIF-2α in neuroblastoma: Estrogen-related receptor alpha (ERRα) regulates HIF2A transcription and correlates to poor outcome.
- Contribution to journal › Article
-
Mark
Neuroblastoma Patient-Derived Orthotopic Xenografts Retain Metastatic Patterns and Geno- and Phenotypes of Patient Tumours.
- Contribution to journal › Article
-
Mark
The water-perfusable tissue fraction of colorectal cancer metastases is increased by the selective PDGF-receptor inhibitor imatinib but not the IL-1 receptor antagonist anakinra, a study using serial dynamic 15O-water PET.
- Contribution to journal › Article
-
Mark
Exosomal microRNAs as Potential Biomarkers in Castration-resistant Prostate Cancer.
- Contribution to journal › Debate/Note/Editorial
-
Mark
MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth.
- Contribution to journal › Article
-
Mark
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
- Contribution to journal › Article
